(Q33404258)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Wu-Chou Su

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

H-S Shiah

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

C-Y Chen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

C-Y Dai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Y-J Lin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

J-Y Chang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

J Whang-Peng

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

P-W Lin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

J-D Huang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

L-T Chen

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

language of work or name

English

0 references

publication date

8 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

17 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

62-73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

17 February 2020

cites work

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials.

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Ras, PI(3)K and mTOR signalling controls tumour cell growth

21 January 2018

1 reference

mTOR and P70 S6 kinase expression in primary liver neoplasms

21 January 2018

1 reference

Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation

21 January 2018

1 reference

Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB.

21 January 2018

1 reference

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

21 January 2018

1 reference

Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma

21 January 2018

1 reference

RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma

21 January 2018

1 reference

Pivotal role of mTOR signaling in hepatocellular carcinoma

21 January 2018

1 reference

A comparison of sirolimus vs. calcineurin inhibitor-based immunosuppressive therapies in liver transplantation

21 January 2018

1 reference

Influence of hepatic impairment on everolimus pharmacokinetics: implications for dose adjustment

21 January 2018

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

Hepatitis B virus genotyping by enzyme-linked immunosorbent assay in Taiwan.

21 January 2018

1 reference

Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors

21 January 2018

1 reference

Phase I clinical and pharmacokinetic study of RAD001 (everolimus) administered daily to Japanese patients with advanced solid tumors

21 January 2018

1 reference

Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors.

21 January 2018

1 reference

Phase 1/2 study of everolimus in advanced hepatocellular carcinoma

21 January 2018

1 reference

Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors

21 January 2018

1 reference

Everolimus for advanced pancreatic neuroendocrine tumors.

21 January 2018

1 reference

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

21 January 2018

1 reference

Everolimus augments the effects of sorafenib in a syngeneic orthotopic model of hepatocellular carcinoma.

21 January 2018

1 reference

Reactivation of hepatitis B.

21 January 2018

1 reference

Calcineurin inhibitor-free immunosuppression using everolimus (Certican) after heart transplantation: 2 years' follow-up from the University Hospital Münster

21 January 2018

1 reference

Regulation of Hepatitis B Virus Replication by the Phosphatidylinositol 3-Kinase-Akt Signal Transduction Pathway

21 January 2018

1 reference

Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy.

21 January 2018

1 reference

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

21 January 2018

1 reference

Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus

21 January 2018

1 reference

Four cases of hepatitis B virus-related fibrosing cholestatic hepatitis treated with lamivudine.

21 January 2018

1 reference

Pilot study: rapamycin in advanced hepatocellular carcinoma

21 January 2018

1 reference

Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer

21 January 2018

1 reference

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

21 January 2018

1 reference

Potentially curative treatment in patients with hepatocellular cancer-results from the liver cancer research network

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23134470%20AND%20SRC:MED&resulttype=core&format=json